Merck KGaA Stock Wiener Boerse

Equities

MRCK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate 04:03:10 2024-04-25 am EDT 5-day change 1st Jan Change
150.6 EUR -1.25% Intraday chart for Merck KGaA +3.74% +6.75%
Sales 2024 * 21.25B 22.77B Sales 2025 * 22.5B 24.11B Capitalization 66.24B 70.98B
Net income 2024 * 2.97B 3.18B Net income 2025 * 3.48B 3.72B EV / Sales 2024 * 3.44 x
Net Debt 2024 * 6.79B 7.28B Net Debt 2025 * 4.83B 5.18B EV / Sales 2025 * 3.16 x
P/E ratio 2024 *
22.3 x
P/E ratio 2025 *
19 x
Employees 62,908
Yield 2024 *
1.52%
Yield 2025 *
1.59%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.43%
1 week+3.74%
Current month-6.84%
1 month-5.69%
3 months+3.67%
6 months+4.09%
Current year+6.75%
More quotes
1 week
145.90
Extreme 145.9
154.50
1 month
144.40
Extreme 144.4
163.75
Current year
141.30
Extreme 141.3
163.75
1 year
135.35
Extreme 135.35
170.55
3 years
134.75
Extreme 134.75
231.20
5 years
80.68
Extreme 80.68
231.20
10 years
74.82
Extreme 74.82
231.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 53 19-04-25
Members of the board TitleAgeSince
Director/Board Member 75 14-05-08
Chairman 67 19-04-25
Director/Board Member 61 12-04-30
More insiders
Date Price Change
24-04-23 152.6 -1.26%
24-04-23 154.5 +4.39%
24-04-22 148 +1.44%
24-04-19 145.9 -0.41%
24-04-18 146.5 -0.37%

End-of-day quote Wiener Boerse, April 23, 2024

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
152.4 EUR
Average target price
182 EUR
Spread / Average Target
+19.46%
Consensus